Acute Kidney Injury in Polytrauma Patients in Intensive Care Unit
NCT ID: NCT04292262
Last Updated: 2020-10-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
60 participants
OBSERVATIONAL
2020-05-01
2020-08-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Incidence and Outcomes of Acute Kidney Injury in Trauma Patients Admitted to Critical Care
NCT05381493
Acute Kidney Injury in Intensive Care Patients
NCT05970952
Acute Kidney Injury in Pediatric Polytrauma Patients at Assiut University Trauma Unit: A Cross-Sectional Study on Incidence and Predictive Risk Factors
NCT06177886
Determination of Perioperative Acute Kidney Injury Incidence
NCT02521350
Intensive Insulin Therapy and Acute Kidney Injury. Analysis Using RIFLE Criteria.
NCT00738504
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Inclusion Criteria:
* Age from 18 to 70 years old males or females
* Injury Sensitivity Score (ISS \>15 )
* Exclusion Criteria:
Patients have end stage liver disease, end stage kidney disease, disseminated malignancy or decompensated heart failure.
Sample size :the calculated sample size is 60 cases of trauma patients.
• All patients' data will be recorded on admission and daily for 7 days:
* Vital signs (blood pressure, heart rate, respiratory rate, body temperature).
* Lab investigations: complete blood count, international normalized ratio, prothrombin time, arterial blood gases, kidney function tests, liver function tests, creatine kinase, creatine kinase-muscle band, creatinine clearance, serum sodium, serum potassium and serum phosphorus will be requested for all patients at admission then daily follow up by creatine kinase, creatine kinase-muscle band, kidney function tests, serum sodium, serum potassium and serum phosphorus for 7 days. Glasgow Coma Scale (GCS), Injury Severity Score (ISS),Urine output (ml/kg/h),RIFLE criteria.,Length of ICU and hospital stay,28 days mortality.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
AKI
Observational
Observational
Non AKI
Observational
Observational
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Observational
Observational
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Injury Sensitivity Score (ISS \>15 )
Exclusion Criteria
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ain Shams University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hanaa Mohamed Abdallah ElGendy MD
Assistant Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hanaa El Gendy
Cairo, Ain Shams University Specialized Hospital, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FMASU M S 289/2020
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.